Charles S. Fermaintt

Statistics

Publications

Citations

415

H-Index

Active since

2015

Affiliations

The University of Texas Southwestern Medical Center(Current)

The University of Texas at San Antonio Health Science Center

Mays Cancer Center at UT Health San Antonio

National Institute of Allergy and Infectious Diseases

Charles S. Fermaintt is an author at The University of Texas Southwestern Medical Center specializing in life sciences, pharmacology, and molecular biology.

Publications per year

2015–2022

Publications

Cytosolic Nuclease TREX1 Regulates Oligosaccharyltransferase Activity Independent of Nuclease Activity to Suppress Immune Activation

Maroof Hasan, Charles S. Fermaintt, Ningguo Gao et al. · Immunity · 2015 · 109 citations · Full text

Life Sciences, Immunology, Molecular Biology +9

Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site

Susan Matthew, Qi-Yin Chen, Ranjala Ratnayake et al. · Proceedings of the National Academy of Sciences · 2021 · 90 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Mammalian STT3A/B oligosaccharyltransferases segregate N-glycosylation at the translocon from lipid-linked oligosaccharide hydrolysis

Hua Lu, Charles S. Fermaintt, Reid Gilmore et al. · Proceedings of the National Academy of Sciences · 2018 · 44 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

DNase-active TREX1 frame-shift mutants induce serologic autoimmunity in mice

Tomomi Sakai, Takuya Miyazaki, Dong-Mi Shin et al. · Journal of Autoimmunity · 2017 · 39 citations · Full text

Life Sciences, Immunology, Molecular Biology +10

Eribulin Activates the cGAS-STING Pathway via the Cytoplasmic Accumulation of Mitochondrial DNA

Charles S. Fermaintt, Leila Takahashi‐Ruiz, Huiyun Liang et al. · Molecular Pharmacology · 2021 · 31 citations · Full text

Medicine, Oncology, Pharmacology +15

1–5 of 9